{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:46:23Z","timestamp":1791927983969,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health Sciences South Carolina Transformative Research Seed Grant","award":["2020000803"],"award-info":[{"award-number":["2020000803"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07316-1","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:25:21Z","timestamp":1784114721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early pharmacotherapy versus no pharmacotherapy: difference in skin conductance response to physical stimuli in infants with neonatal opioid withdrawal syndrome"],"prefix":"10.1186","volume":"26","author":[{"given":"Rachel","family":"Mayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordyn","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Holcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Dickes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Windsor","family":"Sherrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"7316_CR1","doi-asserted-by":"publisher","unstructured":"Ko JY. Vital signs: prescription opioid pain reliever use during pregnancy\u201434 US jurisdictions, 2019. MMWR Morbid Mortal Weekly Rep. 2020;69:897\u2013903. https:\/\/doi.org\/10.15585\/mmwr.mm6928a1.","DOI":"10.15585\/mmwr.mm6928a1"},{"key":"7316_CR2","doi-asserted-by":"publisher","unstructured":"Yen E, Davis JM. The immediate and long-term effects of prenatal opioid exposure. Front Pead. 2022;10:1039055. https:\/\/doi.org\/10.3389\/fped.2022.1039055.","DOI":"10.3389\/fped.2022.1039055"},{"issue":"1","key":"7316_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ppe.12805","volume":"36","author":"R Graeve","year":"2022","unstructured":"Graeve R, Balalian AA, Richter M, Kielstein H, Fink A, Martins SS, et al. Infants\u2019 prenatal exposure to opioids and the association with birth outcomes: A systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2022;36(1):125\u201343.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"7316_CR4","doi-asserted-by":"publisher","unstructured":"Jenkins C, Hudnall M, Hanson C, Lewis D, Parton JM. Cost of Care for Newborns With Neonatal Abstinence Syndrome in a Medicaid Program. JAMA Netw Open. 2024;7(2):e240295. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.0295.","DOI":"10.1001\/jamanetworkopen.2024.0295"},{"key":"7316_CR5","doi-asserted-by":"publisher","unstructured":"Shannon J, Peters K, Blythe S. The Challenges to Promoting Attachment for Hospitalised Infants with NAS. Children. 2021;8(2): 167. https:\/\/doi.org\/10.3390\/children8020167","DOI":"10.3390\/children8020167"},{"key":"7316_CR6","unstructured":"HCUP Fast Stats, Neonatal Abstinence Syndrome Among Newborn Hospitalizations, Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville, MD. 2026. http:\/\/datatools.ahrq.gov\/hcup-fast-stats."},{"key":"7316_CR7","doi-asserted-by":"crossref","unstructured":"Schiff DM, Grossman MR. Beyond the Finnegan Scoring System: Novel Assessment and Diagnostic Techniques for the Opioid-Exposed Infant. Semin Fetal Neonatal Med. 2019;24(2).","DOI":"10.1016\/j.siny.2019.01.003"},{"key":"7316_CR8","doi-asserted-by":"publisher","unstructured":"Timpson W, Killoran C, Maranda L, Picarillo A, Bloch-Salisbury E. A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome. Adv neonatal care: official J Natl Association Neonatal Nurses. 2018;18(1):70\u201378. https:\/\/doi.org\/10.1097\/ANC.0000000000000441.","DOI":"10.1097\/ANC.0000000000000441"},{"issue":"1\u20132","key":"7316_CR9","first-page":"141","volume":"2","author":"LP Finnegan","year":"1975","unstructured":"Finnegan LP, Connaughton JF Jr., Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1\u20132):141\u201358.","journal-title":"Addict Dis"},{"key":"7316_CR10","first-page":"7","volume":"46","author":"HSKM M","year":"2002","unstructured":"M HSKM, O R. Skin conductance correlates with perioperative stress - PubMed. Acta Anaesthesiol Scand. 2002;46:7.","journal-title":"Acta Anaesthesiol Scand"},{"key":"7316_CR11","doi-asserted-by":"publisher","unstructured":"HS. Changes in skin conductance as a tool to monitor nociceptive stimulation and pain - PubMed. Curr Opin Anaesthesiol. 2008;21(6):796\u2013804. https:\/\/doi.org\/10.1097\/ACO.0b013e3283183fe4.","DOI":"10.1097\/ACO.0b013e3283183fe4"},{"key":"7316_CR12","doi-asserted-by":"publisher","unstructured":"Zeiner V, Storm H, Doheny KK. Preterm Infants\u2019 Behavior and Skin Conductance Responses to Nurse Handling in the NICU. J Matern Fetal Neonatal Med. 2015;29(15):2531\u20136. https:\/\/doi.org\/10.3109\/14767058.2015.1092959.","DOI":"10.3109\/14767058.2015.1092959"},{"key":"7316_CR13","doi-asserted-by":"publisher","unstructured":"Munsters J, Walan JT, Holmstr\u00f6m G, Sindelar R. Skin conductance measurement as a selective and continuous pain assessment method during eye examinations for retinopathy of prematurity. Global Pediatr. 2023;4:100056. https:\/\/doi.org\/10.1016\/j.gpeds.2023.100056.","DOI":"10.1016\/j.gpeds.2023.100056"},{"key":"7316_CR14","doi-asserted-by":"publisher","unstructured":"Oji-Mmuo CN, Gardner FC, Doheny KK. Heightened sympathetic arousal is demonstrated by skin conductance responsivity to auditory stimuli in a small cohort of neonates with opiate withdrawal. Brain Res Bull. 2017;138:06\u2013111. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.06.007.","DOI":"10.1016\/j.brainresbull.2017.06.007"},{"key":"7316_CR15","doi-asserted-by":"publisher","unstructured":"Schubach NE, Mehler K, Roth B, Korsch E, Laux R, Singer D, von der Wense A, Treszl A, H\u00fcnseler C.Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns - PubMed. Eur J Pediatrics. 2016;175(6):859\u201368. https:\/\/doi.org\/10.1007\/s00431-016-2716-8.","DOI":"10.1007\/s00431-016-2716-8"},{"key":"7316_CR16","doi-asserted-by":"publisher","unstructured":"Hudson J, Mayo R, Dickes L, Chen L, Sherrill WW, Summey J, et al. Early Treatment for Neonatal Abstinence Syndrome: A Palliative Approach. Am J Perinatol. 2017;34(06):576\u201384. https:\/\/doi.org\/10.1055\/s-0036-1596054.","DOI":"10.1055\/s-0036-1596054"},{"key":"7316_CR17","doi-asserted-by":"publisher","unstructured":"Hudson J, Charron E, Bedi J, Dickes L, Mayo R, Sherrill WW. Managing Abstinence in Newborns (MAiN): Redesigning NAS care for the mother\/baby unit. Healthcare. 2020;8(1):100404. https:\/\/doi.org\/10.1016\/j.hjdsi.2019.100404.","DOI":"10.1016\/j.hjdsi.2019.100404"},{"issue":"3","key":"7316_CR18","doi-asserted-by":"publisher","first-page":"a039669","DOI":"10.1101\/cshperspect.a039669","volume":"11","author":"EA Weller","year":"2021","unstructured":"Weller EA, Crist CR, Reiner CB, Doyle AG, Berrettini HW. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis. Cold Spring Harbor Perspect Med. 2021;11(3):a039669.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"7316_CR19","doi-asserted-by":"publisher","unstructured":"Oji-Mmuo CN, Michael EJ, McLatchy J, Lewis MM, Becker JE, Doheny KK. Skin conductance at baseline and postheel lance reflects sympathetic activation in neonatal opiate withdrawal. Acta Paediatr. 2016;105(3):e99\u2013e106. https:\/\/doi.org\/10.1111\/apa.13287.","DOI":"10.1111\/apa.13287"},{"key":"7316_CR20","doi-asserted-by":"publisher","unstructured":"R\u00f8eggen I, Storm H, Harrison D. Skin conductance variability between and within hospitalised infants at rest - PubMed. Early Hum Dev. 2011;87(1):37\u201342. https:\/\/doi.org\/10.1016\/j.earlhumdev.2010.09.373.","DOI":"10.1016\/j.earlhumdev.2010.09.373"},{"key":"7316_CR21","doi-asserted-by":"publisher","unstructured":"Lyngstad LT, Tandberg BS, Storm H, Ekeberg BL, Moen A. Does skin-to-skin contact reduce stress during diaper change in preterm infants? - PubMed. Early Hum Dev. 2014;90(4):169\u201372. https:\/\/doi.org\/10.1016\/j.earlhumdev.2014.01.011.","DOI":"10.1016\/j.earlhumdev.2014.01.011"},{"key":"7316_CR22","doi-asserted-by":"publisher","unstructured":"Eriksson M, Storm H, Fremming A, Schollin J. Skin conductance compared to a combined behavioural and physiological pain measure in newborn infants. Acta P\u00e6diatrica. 2008;97(1):27\u201330. https:\/\/doi.org\/10.1111\/j.1651-2227.2007.00586.x.","DOI":"10.1111\/j.1651-2227.2007.00586.x"},{"key":"7316_CR23","unstructured":"Inc. SISAS Institute Inc..SAS Software, version 9.4. Cary, NC: SAS Institute Inc.; 2013."},{"issue":"1","key":"7316_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5055\/jom.2009.0006","volume":"5","author":"LM Jansson","year":"2009","unstructured":"Jansson LM, Velez M, Harrow C. The opioid exposed newborn: assessment and pharmacologic management. J Opioid Manag. 2009;5(1):47.","journal-title":"J Opioid Manag"},{"key":"7316_CR25","doi-asserted-by":"publisher","unstructured":"Oji-Mmuo CN, Speer RR, Gardner FC, Marvin MM, Hozella AC, Doheny KK. Prenatal opioid exposure heightens sympathetic arousal and facial expressions of pain\/distress in term neonates at 24\u201348 hours post birth - PubMed. J Matern Fetal Neonatal Med. 2020;33(23):3879\u201386. https:\/\/doi.org\/10.1080\/14767058.2019.1588876.","DOI":"10.1080\/14767058.2019.1588876"},{"key":"7316_CR26","doi-asserted-by":"publisher","unstructured":"Holcomb L, Koob C, Mayo R, Charron E, Dickes L, Sherrill W, et al. It\u2019s a proactive intervention instead of a reactive one: measuring facilitators and barriers regarding readiness to implement a treatment program for infants with neonatal opioid withdrawal syndrome. BMC Health Serv Res. 2023;23(1):754. https:\/\/doi.org\/10.1186\/s12913-023-09734-8.","DOI":"10.1186\/s12913-023-09734-8"},{"key":"7316_CR27","doi-asserted-by":"publisher","unstructured":"Harrison D, Boyce S, Loughnan P, Dargaville P, Storm H, Johnston L. Skin conductance as a measure of pain and stress in hospitalised infants - PubMed. Early Hum Dev. 2006;82(9):603\u20138. https:\/\/doi.org\/10.1016\/j.earlhumdev.2005.12.008.","DOI":"10.1016\/j.earlhumdev.2005.12.008"},{"key":"7316_CR28","doi-asserted-by":"publisher","unstructured":"Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure. N Engl J Med. 2010;363(24):2320\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1005359.","DOI":"10.1056\/NEJMoa1005359"},{"key":"7316_CR29","doi-asserted-by":"publisher","unstructured":"Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, et al. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome. N Engl J Med. 2017;376(24):2341\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1614835.","DOI":"10.1056\/NEJMoa1614835"},{"key":"7316_CR30","doi-asserted-by":"publisher","unstructured":"Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate - PubMed. Drug Alcohol Depend. 2003;70(2 Suppl):S87\u2013101. https:\/\/doi.org\/10.1016\/s0376-8716(03)00062-0.","DOI":"10.1016\/s0376-8716(03)00062-0"},{"key":"7316_CR31","doi-asserted-by":"crossref","unstructured":"Czynski AJ, Davis JM, Dansereau LM, Engelhardt B, Marro P, Bogen DL, et al. Neurodevelopmental outcomes of neonates randomized to morphine or methadone for treatment of neonatal abstinence syndrome. J Pediatr. 2020;219:146\u201351.e1.","DOI":"10.1016\/j.jpeds.2019.12.018"},{"issue":"4","key":"7316_CR32","doi-asserted-by":"publisher","first-page":"e72289","DOI":"10.1002\/hsr2.72289","volume":"9","author":"JM P\u00e9rez-Jim\u00e9nez","year":"2026","unstructured":"P\u00e9rez-Jim\u00e9nez JM, Langa MP, Jimenez MC. Therapeutic Update in Neonatal Opioid Withdrawal Syndrome: Comparative Effectiveness of Pharmacological Treatments and the ESC Assessment Model. Syst Rev Health Sci Rep. 2026;9(4):e72289.","journal-title":"Syst Rev Health Sci Rep"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07316-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:06Z","timestamp":1791925386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07316-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7316"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07316-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were performed in accordance with Prisma Health and Clemson University IRB (Institutional Review Board) guidelines and regulations, US federally mandated bodies established under the DHHS regulations for the Protection of Human Subjects (45 CFR 46). The study protocol was reviewed for compliance and approved by both Prisma Health and Clemson University IRB. Informed consent was obtained from all participating infant\u2019s parents or legal guardians prior to participation in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"981"}}